Memantine Hydrochloride Capsule, Extended Release
Product Images NDC 59651-404

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 59651-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine-fig1.jpg (Memantine Fig1)

A line graph depicting mean change from baseline in SIB score over 24 weeks of treatment, comparing Memantine Hydrochloride Extended-release Capsules 28 mg and placebo. The graph shows clinical improvement or decline along the y-axis and weeks of treatment along the x-axis, with error bars for SEM.*

FDA Label Image

Package Label-principal Display Panel (Titration Pack Carton)

The image shows packaging for Memantine Hydrochloride Extended-Release Capsules in a Titration Pack from Aurobindo Pharma Limited. The pack includes capsules of 7 mg, 14 mg, 21 mg, and 28 mg strengths for once-daily oral use. The front indicates dosage progression over four weeks and provides storage and safety instructions.*

FDA Label Image

Memantine-fig2.jpg (Memantine Fig2)

A cumulative percentage graph comparing the effects of Memantine Hydrochloride Extended-release Capsules 28 mg and placebo on SIB (Severe Impairment Battery) change from baseline in patients. The x-axis represents the SIB change from baseline, while the y-axis shows the cumulative percentage of patients. Two curves depict patient responses for the drug and placebo groups.*

FDA Label Image

Memantine-fig3.jpg (Memantine Fig3)

A line graph showing the mean (± SEM) CIBC-Plus Score over weeks of treatment for memantine hydrochloride extended-release capsules 28 mg compared to placebo. The y-axis represents the score with clinical improvement and decline indicated, and the x-axis shows the weeks of treatment from 0 to 24. The graph depicts clinical improvement for memantine versus clinical decline for placebo over 24 weeks.*

FDA Label Image

Memantine-fig4.jpg (Memantine Fig4)

A bar chart comparing the percentage of patients with various clinical ratings on the CIBIC Plus scale for Memantine Hydrochloride Extended-release Capsules 28 mg versus placebo. Categories include marked improvement, moderate improvement, minimal improvement, no change, minimal worsening, moderate worsening, and marked worsening.*

FDA Label Image

Package Label-principal Display Panel (7 mg (30 Capsules Bottle))

Packaging label for Memantine Hydrochloride Extended-Release Capsules 7 mg, with a quantity of 30 capsules. The label indicates this is a prescription drug for oral use, distributed by Aurobindo Pharma USA, Inc. It includes storage instructions and a barcode on the right side. The label highlights once-daily dosing.*

FDA Label Image

Package Label-principal Display Panel (14 mg (30 Capsules Bottle))

Label for Memantine Hydrochloride Extended-Release Capsules 14 mg, oral dosage form, containing 30 capsules. The label indicates it is for once-daily use, Rx only, and is distributed by Aurobindo Pharma USA, Inc., made in India. Storage instructions recommend 20° to 25°C. The label includes NDC 59651-405-30 and branding for Aurobindo Pharma.*

FDA Label Image

Package Label-principal Display Panel (21 mg (30 Capsules Bottle))

Label for Memantine Hydrochloride extended-release capsules, 21 mg strength, with a quantity of 30 capsules. The label indicates once-daily dosing and is distributed by Aurobindo Pharma USA, Inc. The capsules are made in India by Aurobindo Pharma Limited. The label includes storage instructions and a barcode on the right side.*

FDA Label Image

Package Label-principal Display Panel (28 mg (30 Capsules Bottle))

Label for Memantine Hydrochloride Extended-Release Capsules 28 mg by Aurobindo Pharma Limited. The label states the product contains 30 capsules, is for oral use, and is distributed by Aurobindo Pharma USA. It includes storage instructions and a barcode on the right side.*

FDA Label Image

Package Label-principal Display Panel (Titration Pack)

Memantine Hydrochloride extended-release capsules packaging label from Aurobindo Pharma Limited. The label shows a titration pack with capsules of strengths 7 mg, 14 mg, 21 mg, and 28 mg. It includes dosing instructions with capsules arranged by week and day, and the bottom panel displays empty slots labeled with patient name, date/time, and lot number for tracking. The label features the NDC 59651-408-28 and states Rx only.*

FDA Label Image

Chemical Structure (Memantine Str)

Chemical structure of memantine hydrochloride, showing its molecular framework including amine group and methyl substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.